Ligand Pharmaceuticals (LGND) Curent Deferred Tax Liability (2012 - 2015)

Ligand Pharmaceuticals (LGND) has 4 years of Curent Deferred Tax Liability data on file, last reported at $258000.0 in Q1 2015.

• For the quarter ending Q1 2015, Curent Deferred Tax Liability fell 83.61% year-over-year to $258000.0; the trailing twelve-month figure through Mar 2015 stood at $258000.0 (down 83.61% YoY), and the FY2014 full-year result was $257000.0, down 83.67% from the prior year.
• Curent Deferred Tax Liability held at $258000.0 in Q1 2015, from $257000.0 in the prior quarter.
• In the past five years, Curent Deferred Tax Liability ranged from a high of $1.6 million in Q4 2012 to a low of $257000.0 in Q4 2014.
• A 4-year average of $1.3 million and a median of $1.6 million in 2013 frame the typical range for Curent Deferred Tax Liability.
• Across the five-year window, Curent Deferred Tax Liability retreated 0.44% in 2013 and slumped 83.67% in 2014, its largest moves.
• Tracing LGND's Curent Deferred Tax Liability over 4 years: stood at $1.6 million in 2012, then dropped by 0.44% to $1.6 million in 2013, then tumbled by 83.67% to $257000.0 in 2014, then rose by 0.39% to $258000.0 in 2015.
• Business Quant data shows LGND's Curent Deferred Tax Liability at $258000.0 in Q1 2015, $257000.0 in Q4 2014, and $1.6 million in Q3 2014.